Stocks Health care SYBX
OTC · Health careSynlogic, Inc. (SYBX)
Synlogic, Inc. brought in $0 of revenue over the twelve months to June 30, 2026. It posted a net loss of $655K. In fiscal 2025 capital spending exceeded operating cash flow by $4.4M. At June 30, 2026 it held $13.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Watch SYBX in 60 secondsWhat Synlogic, Inc. does
Synlogic, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker SYBX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$1M | -$0.08 | -$4.4M |
| 2024 | $8K | -$23.4M | -$1.92 | -$31.7M |
| 2023 | $3.4M | -$61.3M | -$9.42 | -$51.8M |
| 2022 | $1.2M | -$66.1M | -$14.79 | -$57.6M |
| 2021 | $1.8M | -$60.6M | -$17.52 | -$52.9M |
| 2020 | $545K | -$59.2M | -$26.52 | -$39.9M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Synlogic, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 11, 2026
- July 29, 2026Activist stake changed SCHEDULE 13D/A
- July 29, 2026Activist stake changed SCHEDULE 13D/A
- July 29, 2026Form 425 filing 425
- July 29, 2026
- May 18, 2026Delisting notice 25-NSE
- May 14, 2026
- April 30, 2026
- April 6, 2026Activist stake changed SCHEDULE 13D/A
- March 12, 2026
Insider trades
What the people running Synlogic, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 29, 2025 | Dooley Mary BethSee Remarks below | Sold | 157 | $284.2 |
Who owns SYBX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Funicular Funds, LP13D, may seek influence with 2 related filers | 28.3% | July 29, 2026 |
| New Enterprise Associates 14, L.P.13D, may seek influence with 7 related filers | 25% | July 29, 2026 |
| Baselake Partners, LP13G, passive with 2 related filers | 9.7% | January 23, 2026 |
| Kryzanowski, John A.13G, passive | 6.27% | February 25, 2025 |
Largest institutional holders
Insiders
1 insiders reported holding 12,744 shares in total, about $14.7K at the last price.
| Holder | Shares |
|---|---|
| Dooley Mary BethSee Remarks below | 12,744 |
Questions about SYBX
What does Synlogic, Inc. do?
Synlogic, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker SYBX.
Is Synlogic, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $655K.
How much revenue does Synlogic, Inc. make?
Over the twelve months to June 30, 2026 Synlogic, Inc. reported revenue of $0.
When did Synlogic, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 14, 2026.
Similar companies
Compare SYBX with
Follow SYBX
Get an email when Synlogic, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow SYBX: get an email when it filesWhere the numbers come from
Financial figures are the values Synlogic, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.